Home / Repaglinide / Czechia
CZ ATC A10BX02 · updated 2 Nov 2026
Repaglinide shortage in Czechia
Is there a Repaglinide shortage in Czechia?
Yes. As of 2 Nov 2026, 6 Repaglinide products are reported short in Czechia, the first since 15 May 2026. The company estimate for the return is 2 Feb 2027 (latest 31 May 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ENYGLID 1MG 1MG TBL NOB 90 | Krka, d.d., Novo mesto, Novo mesto | 15 May 2026 | 2 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | ENYGLID 2MG 2MG TBL NOB 90 | Krka, d.d., Novo mesto, Novo mesto | 1 Aug 2026 | 2 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | ENYGLID 0,5MG 0,5MG TBL NOB 90 | Krka, d.d., Novo mesto, Novo mesto | 26 Aug 2026 | 2 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | VATINID 1MG 1MG TBL NOB 90 anticipated | Novatin Limited, Mgarr | 18 Dec 2026 | 31 May 2027 | Manufacturing problem Výrobní důvody |
| CZ | VATINID 0,5MG 0,5MG TBL NOB 90 anticipated | Novatin Limited, Mgarr | 15 Jan 2027 | 31 May 2027 | Manufacturing problem Výrobní důvody |
| CZ | VATINID 2MG 2MG TBL NOB 90 anticipated | Novatin Limited, Mgarr | 15 Jan 2027 | 15 Apr 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.